Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus

As a clinical setting in which local live biological therapy is already well established, non-muscle invasive bladder cancer (NMIBC) presents intriguing opportunities for oncolytic virotherapy. Coxsackievirus A21 (CVA21) is a novel intercellular adhesion molecule-1 (ICAM-1)-targeted immunotherapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Annels, Nicola E., Arif, Mehreen, Simpson, Guy R., Denyer, Mick, Moller-Levet, Carla, Mansfield, David, Butler, Rachel, Shafren, Darren, Au, Gough, Knowles, Margaret, Harrington, Kevin, Vile, Richard, Melcher, Alan, Pandha, Hardev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035483/
https://www.ncbi.nlm.nih.gov/pubmed/29989024
http://dx.doi.org/10.1016/j.omto.2018.02.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035483/
https://www.ncbi.nlm.nih.gov/pubmed/29989024
http://dx.doi.org/10.1016/j.omto.2018.02.001

Ejemplares similares